Sparrow Pharmaceuticals, Inc. filed a Form D with the Securities and Exchange Commission on 2025-07-01.
Sparrow Pharmaceuticals, Inc. filed a Form D notice of an exempt securities offering with the SEC on July 1, 2025. The filing reports $61.84M sold. Its industry group is Pharmaceuticals. It names Robert Jacks (Executive Officer, Director), Niall O'Donnell (Director), Zach Scheiner (Director) (SEC Form D, July 1, 2025).
Is this your company?
Sell to companies like Sparrow Pharmaceuticals, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-07-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Sparrow Pharmaceuticals, Inc.
Free to see. No signup.
More on the people and the money behind Sparrow Pharmaceuticals, Inc., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Sparrow Pharmaceuticals, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Sparrow Pharmaceuticals, Inc. raises, hires or launches. No email unless you switch it on.
Watch Sparrow Pharmaceuticals, Inc. →Get the full cited report on Sparrow Pharmaceuticals, Inc.
What the filing shows about Sparrow Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Sparrow Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Sparrow Pharmaceuticals, Inc.'s address as 1050 Southwest 6th Street, Suite 1100, Portland, OR 97204.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Sparrow Pharmaceuticals, Inc. See pricing
Sparrow Pharmaceuticals, Inc. is a registered filer with the SEC (CIK 1786949) and has filed since 2024-04-12. 2 filings are on record, the latest on 2025-07-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Sparrow Pharmaceuticals, Inc.'s Form D of 2025-07-01 names Robert Jacks, Niall O'Donnell, Zach Scheiner and 4 more as its officers, directors or promoters.
Its new offerings report $71.84M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Robert Jacks is named as Executive Officer and Director on the Form D that Sparrow Pharmaceuticals, Inc. filed with the SEC on 1 July 2025, one of 7 people that filing names.
Niall O'Donnell is named as Director on the Form D that Sparrow Pharmaceuticals, Inc. filed with the SEC on 1 July 2025, one of 7 people that filing names.
Zach Scheiner is named as Director on the Form D that Sparrow Pharmaceuticals, Inc. filed with the SEC on 1 July 2025, one of 7 people that filing names.
Peter Thompson is named as Director on the Form D that Sparrow Pharmaceuticals, Inc. filed with the SEC on 1 July 2025, one of 7 people that filing names.
Klaus Veitinger is named as Director on the Form D that Sparrow Pharmaceuticals, Inc. filed with the SEC on 1 July 2025, one of 7 people that filing names.
Nanna L?neborg is named as Director on the Form D that Sparrow Pharmaceuticals, Inc. filed with the SEC on 1 July 2025, one of 7 people that filing names.
Jonathan Root is named as Director on the Form D that Sparrow Pharmaceuticals, Inc. filed with the SEC on 1 July 2025, one of 7 people that filing names.
7 people named on the filing — 1 holding an executive role and 6 as directors only.
Named as of the 2025-07-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Sparrow Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Sparrow Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Sparrow Pharmaceuticals, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Sparrow Pharmaceuticals, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Sparrow Pharmaceuticals, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Sparrow Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/sparrow-pharmaceuticals-inc-form-d-25000001